These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What future does the pharmaceutical industry have in the cardiovascular world? Braunwald E Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415 [No Abstract] [Full Text] [Related]
7. Drug therapy in the elderly. Scheidt S; Wenger NK; Weber MA Am J Geriatr Cardiol; 2003; 12(4):223-4. PubMed ID: 12888701 [No Abstract] [Full Text] [Related]
8. Promises kept and broken: new pharmaceuticals. Malik P Can J Cardiol; 2002 May; 18(5):493-4. PubMed ID: 12032574 [No Abstract] [Full Text] [Related]
9. LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders. Megson IL; Leslie SJ Curr Opin Investig Drugs; 2009 Mar; 10(3):276-85. PubMed ID: 19333886 [TBL] [Abstract][Full Text] [Related]
10. [Prescriptions in cardiology]. Vacheron A Ann Pharm Fr; 2005 Mar; 63(2):125-30. PubMed ID: 15976679 [TBL] [Abstract][Full Text] [Related]
11. PHARMAC and cardiovascular health in New Zealand. Moodie P N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762 [No Abstract] [Full Text] [Related]
13. [Long-term use of heparin in cardiovascular diseases. Proposal for a new administration method: aerosols]. Molino N; Belluardo C Minerva Cardioangiol; 1973; 21(7):553-7. PubMed ID: 4756349 [No Abstract] [Full Text] [Related]
15. [Which future in cardiovascular therapy for nitric oxide and its derivatives?]. Parent M; Dupuis F; Maincent P; Vigneron C; Leroy P; Boudier A Ann Pharm Fr; 2013 Mar; 71(2):84-94. PubMed ID: 23537409 [TBL] [Abstract][Full Text] [Related]
16. The impact of molecular medicine upon early cardiovascular drug development. Lunnon MW; Braddock M Br J Clin Pharmacol; 2000 Jul; 50(1):1-8. PubMed ID: 10886110 [No Abstract] [Full Text] [Related]
17. Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives. Iachini Bellisarii F; Radico F; Muscente F; Horowitz J; De Caterina R Cardiovasc Drugs Ther; 2012 Feb; 26(1):55-69. PubMed ID: 22134686 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of atrial fibrillation: an old option with new possibilities. Janko S; Dorwarth U; Hoffmann E Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of coronary heart disease with nitric oxide donors]. Münzel T; Schulz E Pharm Unserer Zeit; 2010 Sep; 39(5):359-68. PubMed ID: 20818685 [No Abstract] [Full Text] [Related]